The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Sacral Nerve Stimulation-Global Market Insights and Sales Trends 2024
Synopsis
Sacral nerve stimulation (SNS) is a medical electrical stimulation therapy that is used to treat long-term bowel control and bladder control symptoms through the modulation of nerves controlling the lower urinary tract and pelvic floor.
The global Sacral Nerve Stimulation market size is expected to reach US$ 1586.1 million by 2029, growing at a CAGR of 11.0% from 2023 to 2029. The market is mainly driven by the significant applications of Sacral Nerve Stimulation in various end use industries. The expanding demands from the Hospitals, Clinics and ASCs,, are propelling Sacral Nerve Stimulation market. Implantable SNS, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the External SNS segment is estimated at % CAGR for the next seven-year period.
The external SNS device is one of the fastest growing product segments in the global sacral nerve stimulation market. Although there is just one external device available in the market, it is FDA approved and has the CE mark. However, this device is completely new to the market in APAC as implantable SNS devices are more popular compared with external SNS devices. With the introduction of new SNS devices by companies such as Nuvectra and Axonics Modulation Technologies, this segment is anticipated to have a positive outlook in the coming years.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sacral Nerve Stimulation, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sacral Nerve Stimulation market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sacral Nerve Stimulation market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sacral Nerve Stimulation sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sacral Nerve Stimulation covered in this report include Medtronic, Boston Scientific, Abbott, Axonics Modulation Technologies, Nuvectra, Cogentix Medical, Cyberonics, Uroplasty, Inc and Neuropace, etc.
The global Sacral Nerve Stimulation market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Medtronic
Boston Scientific
Abbott
Axonics Modulation Technologies
Nuvectra
Cogentix Medical
Cyberonics
Uroplasty, Inc
Neuropace
IntraPace, Inc
Codman & Shurtleff, Inc
Global Sacral Nerve Stimulation market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sacral Nerve Stimulation market, Segment by Type:
Implantable SNS
External SNS
Global Sacral Nerve Stimulation market, by Application
Hospitals
Clinics
ASCs
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Sacral Nerve Stimulation companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Sacral nerve stimulation (SNS) is a medical electrical stimulation therapy that is used to treat long-term bowel control and bladder control symptoms through the modulation of nerves controlling the lower urinary tract and pelvic floor.
The global Sacral Nerve Stimulation market size is expected to reach US$ 1586.1 million by 2029, growing at a CAGR of 11.0% from 2023 to 2029. The market is mainly driven by the significant applications of Sacral Nerve Stimulation in various end use industries. The expanding demands from the Hospitals, Clinics and ASCs,, are propelling Sacral Nerve Stimulation market. Implantable SNS, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the External SNS segment is estimated at % CAGR for the next seven-year period.
The external SNS device is one of the fastest growing product segments in the global sacral nerve stimulation market. Although there is just one external device available in the market, it is FDA approved and has the CE mark. However, this device is completely new to the market in APAC as implantable SNS devices are more popular compared with external SNS devices. With the introduction of new SNS devices by companies such as Nuvectra and Axonics Modulation Technologies, this segment is anticipated to have a positive outlook in the coming years.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sacral Nerve Stimulation, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sacral Nerve Stimulation market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sacral Nerve Stimulation market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sacral Nerve Stimulation sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sacral Nerve Stimulation covered in this report include Medtronic, Boston Scientific, Abbott, Axonics Modulation Technologies, Nuvectra, Cogentix Medical, Cyberonics, Uroplasty, Inc and Neuropace, etc.
The global Sacral Nerve Stimulation market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Medtronic
Boston Scientific
Abbott
Axonics Modulation Technologies
Nuvectra
Cogentix Medical
Cyberonics
Uroplasty, Inc
Neuropace
IntraPace, Inc
Codman & Shurtleff, Inc
Global Sacral Nerve Stimulation market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sacral Nerve Stimulation market, Segment by Type:
Implantable SNS
External SNS
Global Sacral Nerve Stimulation market, by Application
Hospitals
Clinics
ASCs
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Sacral Nerve Stimulation companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Sacral Nerve Stimulation
1.1 Sacral Nerve Stimulation Market Overview
1.1.1 Sacral Nerve Stimulation Product Scope
1.1.2 Sacral Nerve Stimulation Market Status and Outlook
1.2 Global Sacral Nerve Stimulation Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Sacral Nerve Stimulation Market Size by Region (2018-2029)
1.4 Global Sacral Nerve Stimulation Historic Market Size by Region (2018-2023)
1.5 Global Sacral Nerve Stimulation Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Sacral Nerve Stimulation Market Size (2018-2029)
1.6.1 North America Sacral Nerve Stimulation Market Size (2018-2029)
1.6.2 Europe Sacral Nerve Stimulation Market Size (2018-2029)
1.6.3 Asia-Pacific Sacral Nerve Stimulation Market Size (2018-2029)
1.6.4 Latin America Sacral Nerve Stimulation Market Size (2018-2029)
1.6.5 Middle East & Africa Sacral Nerve Stimulation Market Size (2018-2029)
2 Sacral Nerve Stimulation Market by Type
2.1 Introduction
2.1.1 Implantable SNS
2.1.2 External SNS
2.2 Global Sacral Nerve Stimulation Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Sacral Nerve Stimulation Historic Market Size by Type (2018-2023)
2.2.2 Global Sacral Nerve Stimulation Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Sacral Nerve Stimulation Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Sacral Nerve Stimulation Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Sacral Nerve Stimulation Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Sacral Nerve Stimulation Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Sacral Nerve Stimulation Revenue Breakdown by Type (2018-2029)
3 Sacral Nerve Stimulation Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 ASCs
3.2 Global Sacral Nerve Stimulation Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Sacral Nerve Stimulation Historic Market Size by Application (2018-2023)
3.2.2 Global Sacral Nerve Stimulation Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Sacral Nerve Stimulation Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Sacral Nerve Stimulation Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Sacral Nerve Stimulation Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Sacral Nerve Stimulation Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Sacral Nerve Stimulation Revenue Breakdown by Application (2018-2029)
4 Sacral Nerve Stimulation Competition Analysis by Players
4.1 Global Sacral Nerve Stimulation Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sacral Nerve Stimulation as of 2022)
4.3 Date of Key Players Enter into Sacral Nerve Stimulation Market
4.4 Global Top Players Sacral Nerve Stimulation Headquarters and Area Served
4.5 Key Players Sacral Nerve Stimulation Product Solution and Service
4.6 Competitive Status
4.6.1 Sacral Nerve Stimulation Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Medtronic
5.1.1 Medtronic Profile
5.1.2 Medtronic Main Business
5.1.3 Medtronic Sacral Nerve Stimulation Products, Services and Solutions
5.1.4 Medtronic Sacral Nerve Stimulation Revenue (US$ Million) & (2018-2023)
5.1.5 Medtronic Recent Developments
5.2 Boston Scientific
5.2.1 Boston Scientific Profile
5.2.2 Boston Scientific Main Business
5.2.3 Boston Scientific Sacral Nerve Stimulation Products, Services and Solutions
5.2.4 Boston Scientific Sacral Nerve Stimulation Revenue (US$ Million) & (2018-2023)
5.2.5 Boston Scientific Recent Developments
5.3 Abbott
5.3.1 Abbott Profile
5.3.2 Abbott Main Business
5.3.3 Abbott Sacral Nerve Stimulation Products, Services and Solutions
5.3.4 Abbott Sacral Nerve Stimulation Revenue (US$ Million) & (2018-2023)
5.3.5 Axonics Modulation Technologies Recent Developments
5.4 Axonics Modulation Technologies
5.4.1 Axonics Modulation Technologies Profile
5.4.2 Axonics Modulation Technologies Main Business
5.4.3 Axonics Modulation Technologies Sacral Nerve Stimulation Products, Services and Solutions
5.4.4 Axonics Modulation Technologies Sacral Nerve Stimulation Revenue (US$ Million) & (2018-2023)
5.4.5 Axonics Modulation Technologies Recent Developments
5.5 Nuvectra
5.5.1 Nuvectra Profile
5.5.2 Nuvectra Main Business
5.5.3 Nuvectra Sacral Nerve Stimulation Products, Services and Solutions
5.5.4 Nuvectra Sacral Nerve Stimulation Revenue (US$ Million) & (2018-2023)
5.5.5 Nuvectra Recent Developments
5.6 Cogentix Medical
5.6.1 Cogentix Medical Profile
5.6.2 Cogentix Medical Main Business
5.6.3 Cogentix Medical Sacral Nerve Stimulation Products, Services and Solutions
5.6.4 Cogentix Medical Sacral Nerve Stimulation Revenue (US$ Million) & (2018-2023)
5.6.5 Cogentix Medical Recent Developments
5.7 Cyberonics
5.7.1 Cyberonics Profile
5.7.2 Cyberonics Main Business
5.7.3 Cyberonics Sacral Nerve Stimulation Products, Services and Solutions
5.7.4 Cyberonics Sacral Nerve Stimulation Revenue (US$ Million) & (2018-2023)
5.7.5 Cyberonics Recent Developments
5.8 Uroplasty, Inc
5.8.1 Uroplasty, Inc Profile
5.8.2 Uroplasty, Inc Main Business
5.8.3 Uroplasty, Inc Sacral Nerve Stimulation Products, Services and Solutions
5.8.4 Uroplasty, Inc Sacral Nerve Stimulation Revenue (US$ Million) & (2018-2023)
5.8.5 Uroplasty, Inc Recent Developments
5.9 Neuropace
5.9.1 Neuropace Profile
5.9.2 Neuropace Main Business
5.9.3 Neuropace Sacral Nerve Stimulation Products, Services and Solutions
5.9.4 Neuropace Sacral Nerve Stimulation Revenue (US$ Million) & (2018-2023)
5.9.5 Neuropace Recent Developments
5.10 IntraPace, Inc
5.10.1 IntraPace, Inc Profile
5.10.2 IntraPace, Inc Main Business
5.10.3 IntraPace, Inc Sacral Nerve Stimulation Products, Services and Solutions
5.10.4 IntraPace, Inc Sacral Nerve Stimulation Revenue (US$ Million) & (2018-2023)
5.10.5 IntraPace, Inc Recent Developments
5.11 Codman & Shurtleff, Inc
5.11.1 Codman & Shurtleff, Inc Profile
5.11.2 Codman & Shurtleff, Inc Main Business
5.11.3 Codman & Shurtleff, Inc Sacral Nerve Stimulation Products, Services and Solutions
5.11.4 Codman & Shurtleff, Inc Sacral Nerve Stimulation Revenue (US$ Million) & (2018-2023)
5.11.5 Codman & Shurtleff, Inc Recent Developments
6 North America
6.1 North America Sacral Nerve Stimulation Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Sacral Nerve Stimulation Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Sacral Nerve Stimulation Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Sacral Nerve Stimulation Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Sacral Nerve Stimulation Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Sacral Nerve Stimulation Market Dynamics
11.1 Sacral Nerve Stimulation Industry Trends
11.2 Sacral Nerve Stimulation Market Drivers
11.3 Sacral Nerve Stimulation Market Challenges
11.4 Sacral Nerve Stimulation Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
